Evaluating adverse drug reactions in patients taking multiple medications
Official title: The Texas Interprofessional Pharmacogenomics (IPGx) PILOT Cohort
Run by Texas A&M University · NCT06219720 · Data updated 2026-11-12
This study is testing how taking multiple medications affects side effects in at-risk patients to help doctors make better treatment choices.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Texas A&M University Academic / other |
| Locations | 1 site (Bryan, Texas) |
| Status | Recruiting |
| Started | December 15, 2021 |
| Main results expected | November 2026 |
| Study ends | November 2027 |
| Registry record updated | September 12, 2025 |
| Trial ID | NCT06219720 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 45 and over who are taking five or more medications, including over-the-counter drugs and supplements.
✕Probably not a fit
Patients with a history of certain cancers, active liver disease, or those who are in hospice care may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the impact of polypharmacy on adverse drug reactions (ADRs) in at-risk patients using advanced pharmacogenomic technology. The study will analyze data from a pilot cohort to optimize pharmacotherapy regimens and develop a clinical decision support dashboard to identify necessary modifications in drug regimens. Additionally, it will evaluate the capacity of CYP P450 enzymatic pathways in patients on multiple medications and assess the feasibility of integrating informatics workflows between the laboratory and clinical practice.
Why it matters
Potential benefit: If successful, this study could lead to safer and more effective medication management for patients on multiple drugs, reducing the risk of adverse drug reactions.
How similar studies have gone: While there have been various medication management programs, this study's specific focus on pharmacogenomics in polypharmacy is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * People taking 5 or more medications, including over the counter drugs, supplements, natural products, cannabis produces, or other recreational drugs * Ability to give and comprehend the consent process. * Consent to donate urine samples, genetic data through buccal swabs, undergo a comprehensive history and physical examination. * All genders. * Age 45 and over Exclusion Criteria: * Subject has been diagnosed or is being treated for any cancer other than basal cell cancer in the last 5 years. Patients with metastatic melanoma in the last 5 years will be excluded. * Admitted to hospice. * Patient has ever been diagnosed with Hepatitis B or C. * Patient has ever been diagnosed with active liver disease, hepatomegaly, grossly abnormal liver function. Meld score \>10, ALT or AST \>100U/L or an AST/ALT ratio \>2 * Patients taking imidazole antifungal medication. * Declines to participate or interact with staff/share their medical status. * A diagnosis of Alzheimer's disease * Pregnant patients will be excluded * Unable/unwilling to consent. * Unable to verbally communicate and comprehend English/Spanish language.
Where it's running
-
The Interprofessional Pharmacogenomics (IPGx) Clinic
Bryan, Texas, United States Recruiting
Study contacts
- Principal investigator: Kenneth S Ramos, MD — Texas A&M IBT
- Study coordinator: Kenneth S Ramos, MD
- Email: kramos@tamu.edu
- Phone: 7136777740
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pharmacogenetic testing for patients with drug reactions or therapy failure
This study is trying to see if testing patients' genes can help find safer and more effective medications for those who have had bad reactions or who aren't getting better with their current treatments.
-
Lean Beef as Part of a Healthy Meal Plan for Adolescent Girls with PCOS/PMOS
This pilot study tests a lean beef–based meal plan to see if it improves blood sugar control and diet quality in adolescent girls with PCOS/PMOS.
-
Personalized Food Kit to Support Diet in Pregnant Women with Singleton Pregnancies
This trial tests whether giving pregnant people a personalized food kit improves their diet quality and pregnancy outcomes compared with standard prenatal care.
-
Beef versus plant protein for improving muscle-building responses in (pre)frail older adults
This study will test whether a beef meal, a tofu meal, or a placebo produces a stronger muscle-building response in adults aged 65–95 with (pre)frailty.
-
Wearable sweat sensor to noninvasively measure insulin
This research tests a wearable that stimulates sweat and measures insulin to see if sweat insulin levels track blood insulin in adults aged 18–30 and 50–90 with BMI 22–35.
-
Healthy School Recognized Campus: school physical activity and nutrition program
This project will test whether the Healthy School Recognized Campus program and a mentoring approach help increase physical activity, healthy eating, and related health measures for 4th–9th grade students at public schools in Central and East Texas.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.